Semaglutide reduces cardiovascular events by 20% in overweight or obese adults who don't have diabetes: Trial

Source: Medical Xpress

Semaglutide is primarily prescribed for adults with type 2 diabetes but is also approved for chronic weight management in adults with obesity or overweight and have at least one other health issue.

Read More